Your browser doesn't support javascript.
loading
On the cusp of cures: Breakthroughs in Batten disease research.
Brudvig, Jon J; Weimer, Jill M.
Afiliação
  • Brudvig JJ; Pediatrics & Rare Diseases Group, Sanford Research, Sioux Falls, SD, USA; Discovery Science Division, Amicus Therapeutics, Inc, Philadelphia, PA, USA. Electronic address: jill.weimer@sanfordhealth.org.
  • Weimer JM; Pediatrics & Rare Diseases Group, Sanford Research, Sioux Falls, SD, USA; Discovery Science Division, Amicus Therapeutics, Inc, Philadelphia, PA, USA. Electronic address: jon.brudvig@sanfordhealth.org.
Curr Opin Neurobiol ; 72: 48-54, 2022 02.
Article em En | MEDLINE | ID: mdl-34571324
ABSTRACT
Batten disease is a family of rare, lysosomal disorders caused by mutations in one of at least 13 genes, which encode a diverse set of lysosomal and extralysosomal proteins. Despite decades of research, the development of effective therapies has remained intractable. But now, the field is experiencing rapid, unprecedented progress on multiple fronts. New tools are providing insights into previously unsolvable problems, with molecular functions now known for nine Batten disease proteins. Protein interactome data are uncovering potential functional overlap between several Batten disease proteins, providing long-sought links between seemingly disparate proteins. Understanding of cellular etiology is elucidating contributions from and interactions between various CNS cell types. Collectively, this explosion in insight is hastening an unparalleled period of therapeutic breakthroughs, with multiple therapies showing great promise in preclinical and clinical studies. The coming years will provide a continuation of this rapid progress, with the promise of effective treatments giving patients hope.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lipofuscinoses Ceroides Neuronais Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lipofuscinoses Ceroides Neuronais Idioma: En Ano de publicação: 2022 Tipo de documento: Article